Study of FID-022 in Participants With Advanced Solid Tumors
Study of FID-022 in Participants With Advanced Solid Tumors
Recruiting · NCT06694480 · Registry updated 2026-09-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of FID-022 in Participants With Advanced Solid Tumors | Advanced Solid Tumors | Recruiting | Phase 1 | 2026-09-08 | NCT06694480 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Fulgent Pharma LLC. | 2 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| City of Hope | Duarte | United States | 238 |
| Moffitt Cancer Center | Tampa | United States | 523 |
| USC/Norris Comprehensive Cancer Center and Hospital | Los Angeles | United States | 2 |